Event Series: Deadlines

DEADLINE: Investor Readiness Program (IRP)

23 March @ 8:00 am - 9:00 am AWST

AusBiotech Investor Readiness Program (IRP) is officially open for year round applications. This is a brilliant opportunity for companies from discovery stage teams to ASX listed entities to gain structured investor informed feedback on their translational pathway and capital positioning at no cost.

For ASX-listed life sciences companies, the IRP can help sharpen how milestones, evidence and capital needs are communicated to the market. It is designed to support clearer investor-facing positioning at a time when many companies are working to align development progress with capital strategy. AusBiotech’s IRP provides structured, investor-informed feedback to help life sciences companies strengthen their translational pathway and capital positioning — from early development through to institutional readiness. There is no cost to apply and you do not need to be a member.

To be considered for the Early Stage Innovation Forum at AusMedtech 2026 or AusBiotech Invest Perth please ensure your submission is in by 23 March.